» Authors » Pornngarm Limtrakul

Pornngarm Limtrakul

Explore the profile of Pornngarm Limtrakul including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 52
Citations 1132
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
21.
Umsumarng S, Pintha K, Pitchakarn P, Sastraruji K, Sastraruji T, Ung A, et al.
Chem Pharm Bull (Tokyo) . 2013 Jan; 61(4):399-404. PMID: 23358236
Resistance to chemotherapy in cancer patients has been correlated to the overexpression of the ATP-binding cassette (ABC) drug transporters including P-glycoprotein (P-gp) that actively efflux chemotherapeutic drugs from cancer cells....
22.
Cine N, Limtrakul P, Sunnetci D, Nagy B, Savli H
Exp Ther Med . 2012 Dec; 5(1):23-27. PMID: 23251236
Curcumin, or diferuloylmethane, is a major chemical component of turmeric (Curcuma longa Linn.) that has been consumed as a dietary spice through the ages. This yellow-colored polyphenol has a notably...
23.
Wongsirisin P, Yodkeeree S, Pompimon W, Limtrakul P
Chem Pharm Bull (Tokyo) . 2012 Aug; 60(10):1283-9. PMID: 22863844
In this study, we focused the effects of crebanine, an alkaloid isolated from the tuber of Stephania venosa, on various human cancer cells. Crebanine treatment was found to significantly inhibit...
24.
Punfa W, Yodkeeree S, Pitchakarn P, Ampasavate C, Limtrakul P
Acta Pharmacol Sin . 2012 May; 33(6):823-31. PMID: 22580738
Aim: To compare the anti-cancer activity and cellular uptake of curcumin (Cur) delivered by targeted and non-targeted drug delivery systems in multidrug-resistant cervical cancer cells. Methods: Cur was entrapped into...
25.
Pitchakarn P, Suzuki S, Ogawa K, Pompimon W, Takahashi S, Asamoto M, et al.
Food Chem Toxicol . 2012 Jan; 50(3-4):840-7. PMID: 22266361
In this study, we focused on the in vitro effects of Kuguacin J (KuJ), a purified component of bitter melon (Momordica charantia) leaf extract (BMLE), on the androgen-independent human prostate...
26.
Iangcharoen P, Punfa W, Yodkeeree S, Kasinrerk W, Ampasavate C, Anuchapreeda S, et al.
Arch Pharm Res . 2011 Nov; 34(10):1679-89. PMID: 22076768
Targeting therapeutics to specific sites can enhance the efficacy of drugs, reduce required doses as well as unwanted side effects. In this work, using the advantages of the specific affinity...
27.
Phromnoi K, Prasad S, Gupta S, Kannappan R, Reuter S, Limtrakul P, et al.
Mol Pharmacol . 2011 Aug; 80(5):889-99. PMID: 21816954
Because constitutive activation of signal transducers and activators of transcription-3 (STAT3) has been linked with cellular transformation, survival, proliferation, chemoresistance, and angiogenesis of various tumor cells, agents that can suppress...
28.
Chanmahasathien W, Ohnuma S, Ambudkar S, Limtrakul P
Planta Med . 2011 Jul; 77(18):1990-5. PMID: 21786221
The resistance to chemotherapeutic drugs by cancer cells is considered to be one of the major obstacles for success in the treatment of cancer. A major mechanism underlying this multidrug...
29.
Pitchakarn P, Suzuki S, Ogawa K, Pompimon W, Takahashi S, Asamoto M, et al.
Cancer Lett . 2011 Mar; 306(2):142-50. PMID: 21429659
In this study, we focused on the effects of a bitter melon (Momordica charantia) leaf extract (BMLE) and a purified component, Kuguacin J (KuJ), on androgen-dependent LNCaP human prostate cancer...
30.
Pitchakarn P, Ohnuma S, Pintha K, Pompimon W, Ambudkar S, Limtrakul P
J Nutr Biochem . 2011 Mar; 23(1):76-84. PMID: 21414769
Multidrug resistance (MDR) is a major factor in the failure of chemotherapy in cancer patients. Resistance to chemotherapy has been correlated to the overexpression of ABC drug transporters including P-glycoprotein...